Pharmacogenetics Study in Taiwan's Ethnic Groups
The Pharmacogenetics Study of Drug-Metabolising Enzyme Genetic Polymorphisms in Aboriginal and Minnan/Hakka Ethnic Groups in Taiwan
1 other identifier
observational
350
1 country
1
Brief Summary
This main purpose of this study is to understand the difference and distribution of drug-metabolizing enzyme genetic polymorphisms among Taiwan ethnicities. The subjects of study include Atayal, Pawlan, Yami, Tsou, Ami, Minnan and Hakka. We anticipate establishing a reference for the clinical medication in various ethnic groups according to the difference and distribution of the genetic polymorphisms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2006
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
April 10, 2007
CompletedFirst Posted
Study publicly available on registry
April 11, 2007
CompletedApril 11, 2007
April 1, 2007
April 10, 2007
April 10, 2007
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- This study includes seven groups, and each of them has 50 independent samples for drug-metabolizing enzyme genetic polymorphism analysis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mackay Memorial Hospitallead
- Department of Healthcollaborator
Study Sites (1)
Mackay Memorial Hospital
Taipei, 100, Taiwan
Related Publications (1)
Chu CC, Lin M, Nakajima F, Lee HL, Chang SL, Juji T, Tokunaga K. Diversity of HLA among Taiwan's indigenous tribes and the Ivatans in the Philippines. Tissue Antigens. 2001 Jul;58(1):9-18. doi: 10.1034/j.1399-0039.2001.580102.x.
PMID: 11580850BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Li-Jiuan Shen, Ph.D.
School of Pharmacy, National Taiwan University
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 10, 2007
First Posted
April 11, 2007
Study Start
December 1, 2006
Study Completion
April 1, 2007
Last Updated
April 11, 2007
Record last verified: 2007-04